News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abiomed (ABMD) Announces Several Reimbursement Milestones


3/4/2013 11:32:17 AM

DANVERS, Mass., March 4, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today provided a reimbursement update. Abiomed announced several recent Impella coverage decisions from national payers including Humana, UnitedHealthcare Medicare Risk, Independence Blue Cross and Capital BlueCross. The recently updated coverage decisions include new Impella policies in the payers' commercial and/or Medicare Advantage plans.

Read at GlobeNewswire


comments powered by Disqus
Abiomed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES